View Press Releases
-
Supply of ISO 9001:2015 Certified Fluoropolymers to Step up Scientific Research
Recognized for their unmatched chemical and temperature resistance properties, fluoropolymer materials are widely used in many industries.
Nov 9, 2022
-
Emmes rapidly expands in India – driven by deep vaccines and infectious diseases expertise and enhanced study startup capabilities
-
BARDA supports development of novel AI/ML-based digital apps for visual and auditory symptomatic infectious disease detection
I wanted to share news of BARDA launching the “Digital Medical Countermeasures” program to develop digital solutions with VisualDx and Virufy to aid in infectious disease detection and pandemic preparedness. With this partnership, VisualDx is creating an app that leverages AI/ML-based image analysis and questionnaires to analyze skin lesions and identify pox-based viruses (monkeypox, smallpox, etc.), and can be modified for future outbreaks. The app will inform users about their skin conditions in real-time to streamline appropriate care and treatment options.
Nov 8, 2022
-
Rho Appoints Clinical Oncologist and Industry Veteran J. Marc Pipas, MD, As Senior Medical Director
Dr. Pipas’ Experience Enhances Rho’s Oncology Capabilities
Oct 18, 2022
-
Inizio expands senior leadership team with key appointment
-
AbsoluteCare Selects ZeOmega for Chronic Care Management for High-Risk Patient Populations
ZeOmega Helps Healthcare Provider Reach and Manage Critically Ill Patients
Nov 7, 2022
-
Quanticate announces plans to accelerate growth in North America
-
Lifeasible Released a Platform Based on High-throughput Plant Phenotyping
-
COFEPRIS Certifies 5 CTL Amedica Devices for Commercialization, Marketing in Mexico
CTL Amedica Corporation has received official certification from COFEPRIS, the agency charged with overseeing the quality of medical devices and products made in and imported into Mexico, to commercialize and market the Valeo II silicon nitride interbody product line in Mexico. The Valeo II interbody devices are made entirely of silicon nitride, which demonstrates a superior osteogenic response for enhanced fusion, promotes unique anti-bacterial properties and provides comprehensive imaging across all modalities. CTL Amedica is the world’s exclusive provider of silicon nitride spine products, and the certification includes 5 silicon nitride devices.
Nov 7, 2022
-
Matexcel Enlarged Its Offerings for Co-based Metal Powder Products
-
Creative BioMart Provides MHC Solutions for Cell Therapy & Vaccine Development
-
Profacgen Updated Its In Silico Protein-protein Interactions Prediction Service
-
RCH Solutions To Present at 20/15 Visioneers’ Virtual Cloud Lab, HTE and Lab Automation Conference
Leading a talk on Next Generation Compute Environments, the long-time provider of computing consulting and execution services exclusively to R&D teams in the Life Sciences will take the virtual stage on November 8, 2022.
Nov 6, 2022
-
Full-Scale PROTAC In Vivo Evaluation Services to Facilitate PROTAC Drug R&D
BOC Sciences can take care of the PROTAC in vivo evaluation workload for clients with a transparent project process and comprehensive evaluation reports to facilitate PROTAC discovery and development programs prior to clinical trials.
Nov 6, 2022
-
Synthetic Biology Platform: Meet All Synthetic Biology Demands in One Place
The Synthetic Biology Platform is designed to program comprehensive biosynthesis development in one place.
Nov 6, 2022
-
New tool to identify patients at high risk of Kidney Dysfunction presented at American Society of Nephrology Conference
A new tool has been developed to identify those diabetes patients who are at risk of developing Chronic Kidney Disease. Early diagnosis can lead to earlier treatment and save lives.
Nov 6, 2022
-
CD ComputaBio Introduces Four Docking Software for Drug Development
-
Pronalyse Supports Drug Discovery with the Launch of Biosimilar Analysis Solutions
-
Creative Proteomics Boosts Your Project with Unknown Metabolite Identification Services
-
Creative Proteomics Cytokine Announces the Launch of Chemokine Detection Service